MedPath
HSA Approval

MAXITROL STERILE OPHTHALMIC SUSPENSION

SIN04358P

MAXITROL STERILE OPHTHALMIC SUSPENSION

MAXITROL STERILE OPHTHALMIC SUSPENSION

May 2, 1990

NOVARTIS (SINGAPORE) PTE LTD

NOVARTIS (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVARTIS (SINGAPORE) PTE LTD
Licence HolderNOVARTIS (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SOLUTION

OPHTHALMIC

Medical Information

S01CA01

dexamethasone and antiinfectives

Manufacturer Information

NOVARTIS (SINGAPORE) PTE LTD

ALCON-COUVREUR NV

Active Ingredients

DEXAMETHASONE

1.0 mg/ml

Dexamethasone

NEOMYCIN SULPHATE

3500 iu/ml

Neomycin

POLYMYXIN B SULPHATE

6000 iu/ml

Polymyxin B

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MAXITROL STERILE OPHTHALMIC SUSPENSION - HSA Approval | MedPath